Stock listing
Revolution Medicines, Inc.
Selected listing: A2PYWG · LS · EUR · DE
Revolution Medicines, Inc. (Lang & Schwarz: A2PYWG), Health Technology. Latest release Oct 5, 2026: Revolution Medicines Begins Treating Patients in Phase 3…
- Ticker
- Lang & Schwarz: A2PYWG
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Revolution Medicines, Inc.
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer
October 4, 2026
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer
October 5, 2026
Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer
September 14, 2026
New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer
September 2, 2026
U.S. FDA Approves Revolution Medicines' RASONQUE (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
August 27, 2026
Events
Research Revolution Medicines, Inc.
Revolution Medicines, Inc. company profile
View the public company page for Revolution Medicines, Inc. on 6ix.
Revolution Medicines, Inc. news
Read company news and market updates connected to Revolution Medicines, Inc..
Revolution Medicines, Inc. investor events
Find investor webinars, events, and replay context for Revolution Medicines, Inc..
Alternate listings
RVMD:NASDAQ
US · USD
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is A2PYWG:LS.
42Z:GETTEX
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is A2PYWG:LS.
A2PYWG:LSX
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is A2PYWG:LS.
1RVMD:MIL
IT · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is A2PYWG:LS.
42Z:TRADEGATE
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is A2PYWG:LS.
RVMD:BX
CH · CHF
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is A2PYWG:LS.
RVMD:BOATS
US · USD
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is A2PYWG:LS.
RVMD:BMV
MX · MXN
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is A2PYWG:LS.
42Z:DUS
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is A2PYWG:LS.
42Z:FWB
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is A2PYWG:LS.
42Z:HAM
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is A2PYWG:LS.
42Z:MUN
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is A2PYWG:LS.